Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Post Marketing Study on Pluvicto in Korea

 		Metastatic Castration-resistant Prostate Cancer South Korea NCT06514521

A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China

 		Paroxysmal Nocturnal Hemoglobinuria China NCT06931691

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC

 		Metastatic Castration Resistant Prostate Cancer (mCRPC) Phase2 United States NCT06894511

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

 		Atopic Dermatitis Phase2 Canada
United States 		NCT06947993

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

 		Lupus Nephritis Phase3 China
Hungary
Singapore
South Korea
View All
 NCT06711887

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

 		Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Phase3 Canada
France
Germany
Hungary
Netherlands
Poland
South Korea
Spain
United States
View All
 NCT06784752

Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation

 		Multiple Sclerosis United States NCT06668324

RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

 		Chronic Myelogenous Leukemia in Chronic Phase Saudi Arabia NCT06684964

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

 		Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) Phase2 France
Germany
Poland
Spain
United States
View All
 NCT06865651

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

 		Hypertension Phase2 Japan
Singapore
United States 		NCT06857955